Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/27393
Título: Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells : correlation with polysomnographic and metabolic parameters
Autor: Feliciano, Amélia
Vaz, Fátima
Torres, Vukosava M.
Coelho, Cristina Valentim
Silva, Rita
Prosinecki, Vesna
Alexandre, Bruno M.
Carvalho, Ana S.
Matthiesen, Rune
Malhotra, Atul
Pinto, Paula
Bárbara, Cristina
Penque, Deborah
Palavras-chave: Obstructive sleep apnea
Peroxiredeoxin-2
Red blood cells
Biomarkers
Data: Fev-2017
Editora: Elsevier
Citação: Biochimica et Biophysica Acta 1863 (2017) 621–629
Resumo: We have examined the effects of Obstructive Sleep Apnea (OSA) on red blood cell (RBC) proteome variation at evening/morning day time to uncover new insights into OSA-induced RBC dysfunction that may lead to OSA manifestations. Dysregulated proteins mainly fall in the group of catalytic enzymes, stress response and redox regulators such as peroxiredoxin 2 (PRDX2). Validation assays confirmed that at morning the monomeric/dimeric forms of PRDX2 were more overoxidized in OSA RBC compared to evening samples. Six month of positive airway pressure (PAP) treatment decreased this overoxidation and generated multimeric overoxidized forms associated with chaperone/transduction signaling activity of PRDX2. Morning levels of overoxidized PRDX2 correlated with polysomnographic (PSG)-arousal index and metabolic parameters whereas the evening level of disulfide-linked dimer (associated with peroxidase activity of PRDX2) correlated with PSG parameters. After treatment, morning overoxidized multimer of PRDX2 negatively correlated with fasting glucose and dopamine levels. Overall, these data point toward severe oxidative stress and altered antioxidant homeostasis in OSA RBC occurring mainly at morning time but with consequences till evening. The beneficial effect of PAP involves modulation of the redox/oligomeric state of PRDX2, whose mechanism and associated chaperone/transduction signaling functions deserves further investigation. RBC PRDX2 is a promising candidate biomarker for OSA severity and treatment monitoring, warranting further investigation and validation.
Descrição: © 2016 Published by Elsevier B.V.
Peer review: yes
URI: http://hdl.handle.net/10451/27393
DOI: 10.1016/j.bbadis.2016.11.019
ISSN: 1388-1981
Versão do Editor: https://www.journals.elsevier.com/bba-molecular-basis-of-disease
Aparece nas colecções:FM-ISAMB-Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Evening_morning_peroxiredoxin.pdf1,03 MBAdobe PDFVer/Abrir    Acesso Restrito. Solicitar cópia ao autor!


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.